DOWNSIZED goes over the 28% figure shared at EASD 2026 and the catch it says comes with it.
Recap by typeshit. Full story at DOWNSIZED.
Topol points to work suggesting the body's own GLP-1 family peptides help reduce inflammation in the gut. Details are thin, so tap through for the study.
Medscape explores whether GLP-1 medicines might help keep people with schizophrenia out of the hospital. Tap through for the evidence behind the idea.
The weight loss drug class started with a lizard. A short local feature looks at how the Gila monster led researchers to GLP-1 medicines.
Healio
At the Cardiometabolic Health Congress, the UAB professor asked whether maximal weight loss is optimal and flagged that most non-diabetic patients quit GLP-1s within two years.
The free session covers nutrition, exercise, side effects and common myths for people curious about GLP-1 medications. A local event listing.
CBS19 reports on research suggesting app-based support and structured meal plans may help people hold their weight after coming off GLP-1 drugs.
Loading…